Pharmaceuticals
INOVIO Interim Results of an Open-Label Phase 2 Trial of VGX-3100 Show Efficacy Against HPV-associated Vulvar Dysplasia
PLYMOUTH MEETING, Pennsylvania, March 30, 2020 /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (NASDAQ: INO) today reported interim results from an open-label Phase 2 trial designed to evaluate the safety and efficacy of VGX-3100 in women with vulvar dysplasia, also known as high grade squamous int...
2020-03-30 21:00
2950
OssDsign Receives Regulatory Approval and Prepares for Launch in Japan
STOCKHOLM, March 30, 2020 /PRNewswire/ -- OssDsign AB (publ) today announced that the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has granted approval of OssDsign Cranial PSI for the Japanese market. OssDsign plans to launch OssDsign Cranial PSI inJapan together with a national dis...
2020-03-30 20:42
1712
Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19; Landmark New Partnership with U.S. Department of Health & Human Services; and Commitment to Supply One Billion Vaccines Worldwide for Emergency Pandemic Use
Johnson & Johnson and BARDA Together Commit More than $1 Billion to Novel Coronavirus Vaccine Research and Development; Company Expects to Initiate Phase 1 Human Clinical Studies of Vaccine Candidate at Latest bySeptember 2020 Johnson & Johnson Will Establish New U.S. Vaccine Manufacturing Capab...
2020-03-30 19:32
4698
CSPC Pharmaceutical Announces 2019 Annual Results
Profit Attributable To Shareholders Increased 20.6% to RMB3,714 Million Innovative Drug Business Continued to Deliver Strong Growth New Products Launched Helped to Sustain Growth HONG KONG, March 30, 2020 /PRNewswire/ -- CSPC Pharmaceutical Group Limited (HKEx: 01093) ("CSPC Pharmaceutical" or the...
2020-03-30 12:34
3679
GenScript ProBio Congratulates XlifeSciences on the Start of TAEST16001 Early Phase Clinical Trial
NANJING, China, March 27, 2020 /PRNewswire/ -- Guangzhou XlifeSciences, a partner of GenScript ProBio (GenScript's CDMO segment), announced that the early phase clinical trial of TAEST16001 project has been started. GenScript ProBio extends congratulations on this. This clinical trial project is...
2020-03-27 21:00
2833
Foresee Pharmaceuticals and Accord Healthcare Announce MAA Submission for Camcevi(R) 42mg
TAIPEI, March 27, 2020 /PRNewswire/ -- Foresee Pharmaceuticals Co., Ltd. (6576.TWO) ("Foresee") and Accord Healthcare announced today that a Marketing Authorization Application (MAA) forCamcevi® 42mg (FP-001 LMIS 50mg), a ready-to-use 6-month depot formulation of leuprolide mesylate, has been su...
2020-03-27 19:53
3965
INOVIO Reports Positive Interim Phase 2 VGX-3100 Results In Patients with HPV-associated Anal Dysplasia
- VGX-3100 DNA medicine cleared high-risk HPV 16/18-associated precancerous lesions in 50% of patients, and reduced the number of lesions in 75% of patients - Data to be presented at the 2020 American Society for Colposcopy and Cervical Pathology (ASCCP) meeting PLYMOUTH MEETING, Pa., March 26, ...
2020-03-26 21:00
3611
Nippon Express Receives GDP Certification for Temperature-controlled Facility in Narita Area
TOKYO, March 26, 2020 /PRNewswire/ -- Nippon Express Co., Ltd., has received Good Distribution Practice (GDP) certification indicating compliance with industry-accepted standards for the proper distribution of pharmaceutical products for its in-transit air cargo storage services at the Narita Te...
2020-03-26 15:00
3027
XABT donates 2019-nCoV nucleic acid detection kits to Italy
BEIJING, March 26, 2020 /PRNewswire/ -- On March 19, the 2019-nCoV Detection Kit and Nucleic Acid Extraction Donation & Shipment Ceremony was held inBeijing . Beijing Applied Biological Technologies Co., Ltd. (XABT) was invited to the event at which the biologics maker donated an allotment of nucl...
2020-03-26 10:14
5410
Innovent Biologics Enters into a Collaboration with Alector to Develop and Commercialize Anti-SIRP-alpha Antibody in China
SUZHOU, China, March 26, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent" or the "Company") (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, and A...
2020-03-26 07:00
4519
PharmaExcipients China 2020 to be held at SNIEC from June 22-24
SHANGHAI, March 25, 2020 /PRNewswire/ -- CPhI China launched the PharmaExcipients China in 2013, which has grown rapidly into a one-stop high-end trade exchange platform.The exhibition will be hosted at the Shanghai New International Expo Centre (SNIEC) fromJune 22-24, 2020 and gather over 100 C...
2020-03-25 16:16
2245
Precision NanoSystems Announces Partnership with Fujifilm for the Development and GMP Manufacturing of Nanoparticle Based Therapeutics
VANCOUVER, March 25, 2020 /PRNewswire/ -- Precision Nanosystems, Inc. (PNI), a global leader in enabling transformative nanomedicines announced today that the company entered into a license agreement with FUJIFILM Corporation to adopt PNI's NanoAssemblr™ technology and complete suite of instrumen...
2020-03-25 08:00
1721
OncoQuest Announces Publication of Two Reports Related to Oregovomab Phase 2 Clinical Trial, the Company's Lead Investigational Drug in Frontline Ovarian Cancer
EDMONTON, Alberta, March 24, 2020 /PRNewswire/ -- OncoQuest Inc. ("OncoQuest" or the "Company"), a privately held, cancer immunotherapy company today announced the publication of two reports relating to the recently completed Phase 2 trial conducted in the US andItaly utilizing oregovomab, the Co...
2020-03-24 18:00
1813
Drug Registration Approval Granted for Sihuan Pharmaceutical's Pediatric Compound Amino Acid Injection (18AA-II)
HONG KONG, March 23, 2020 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. (HKEX: 0460, "Sihuan Pharmaceutical" or the "Company", together with its subsidiaries, the "Group") is pleased to announce that drug registration approval has been granted by the National Medical Products Administ...
2020-03-23 17:57
5150
European and U.S. Antitrust Authorities Clear Acquisition of Select Danaher Life Science Businesses by Sartorius
GOTTINGEN, Germany, March 20, 2020 /PRNewswire/ -- On March 18 and March 19, 2020 respectively, the European Commission and the U.S. Federal Trade Commission cleared the proposed acquisition of select Danaher businesses by Sartorius. Both approvals are an important milestone for the transaction ...
2020-03-20 20:36
9521
Gencurix Releasing New Coronavirus Diagnostic Kit in the EU
SEOUL, South Korea, March 20, 2020 /PRNewswire/ -- A new diagnostic kit for the COVID-19, developed by Gencurix (KONEX 229000), will be available soon in Europe. GenePro COVID-19 Detection Test, developed in accordance to the WHO (World Health Organization) guidance for 'Laboratory testing for 2...
2020-03-20 16:23
2603
Prof. Oliver Sartor Joins Clarity's Advisory Board
SYDNEY, March 20, 2020 /PRNewswire/ -- Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that Prof.Oliver Sartor has joined Clarity's Advisory Board. Prof. Sartor is a medical oncologist and an internationally recognised exp...
2020-03-20 12:29
2398
Zhejiang Hisun Pharmaceutical Co. Ltd.: Favipiravir Works - Preliminary Clinical Studies Suggest Positive Effects on COVID-19 Patients
ZHEJIANG, China, March 20, 2020 /PRNewswire/ -- Since the outbreak of COVID-19,
people around the globe have been eagerly awaiting a real breakthrough on its
treatment. Fortunately, a silver lining seems finally to be showing up.
2020-03-20 03:50
4247
InxMed Announces Dosing of First Patient in a Phase Ib Trial of IN10018 as Monotherapy and Combination Therapy in Patients with Uveal Melanoma and NRAS mutant Metastatic Melanoma in the United States
SHANGHAI, March 17, 2020 /PRNewswire/ -- InxMed (Shanghai) Co., Ltd. ("InxMed" or "Company"), a clinical stage biotech company dedicated to developing innovative, individualized medicines with international impact, announced today that the company has dosed first patient in its Phase Ib clinical ...
2020-03-17 09:05
3041
Yuyu Pharma, Medicine Donation to Korean Red Cross
SEOUL, South Korea, March 16, 2020 /PRNewswire/ -- Yuyu Pharma (CEO Robert Wonsang Yu) (KRX 000220) has donated vitamins, anti-fever medicine, and anti-allergy medication to help the people in Daegu and Gyeongbuk regions, which have both been hit hard by the Coronavirus. These include the vitamin...
2020-03-16 08:00
3010
Week's Top Stories
Most Reposted
Cornerstone Robotics Raises over US$70 million Funding to Forge Accessibility in Robotic Surgery
[Picked up by 323 media titles]
2025-01-13 09:05
URBAN REVIVO Celebrates Lunar New Year with Unique Collaboration with Artist Mercedes Bellido
[Picked up by 294 media titles]
2025-01-13 10:44
RuggON Launches VIKING II: Transforming Fleet Management with Unmatched Technology and Flexibility
[Picked up by 287 media titles]
2025-01-14 21:00
Gen Z Travelers Drive Buy Now, Plan Later Travel Bookings by Over 20%: Fliggy's 2024 Buy Now Plan Later Travel Insight
[Picked up by 286 media titles]
2025-01-10 16:04VANTAGE FOUNDATION SUPPORTS GRAB INDONESIA IN EMPOWERING WOMEN DRIVER-PARTNER
[Picked up by 280 media titles]
2025-01-09 18:26
Most Read
Hyundai Motor Group Partners with NVIDIA to Accelerate Development of AI Solutions for Future Mobility
2025-01-10 01:00
20406
AIMA Unveils Game-Changing 2025 eBike Lineup at CES: Better Performance, More Freedom
2025-01-09 02:34
6498
RingConn Takes Center Stage at CES 2025 with Innovative Wearables: Gen 2 and Gen 2 Air
2025-01-11 01:00
5688
Boqii Announces ADS Ratio Change
2025-01-11 05:30
4985
Sino Land Included in Dow Jones Sustainability World Index
2025-01-10 22:01
4966
